News - Page 94

TLDR: Key Points: XTEND, an Israeli drone company, secured military contracts and venture capital funding but also sought charitable donations. XTEND’s drones are used for surveillance and combat, with reports of their

TLDR: venBio has raised $528 million for its fifth fund, venBio Fund V, which will focus on investing in life science companies. The fund will target opportunities in the healthcare and biotechnology

TLDR: Alix Rimington, former head of Amatil X, has been named chief of staff of Woolworths Group. She will also continue in her roles as general manager of global strategic alliances and

TLDR: 18 institutional entities in Israel to receive $155 million for investment in venture capital funds for startups. The Yozma Fund 2.0 aims to incentivize institutional entities to invest in Israeli high-tech

TLDR: Retired U.S. Army General Paul Nakasone joins Ballistic Ventures as Strategic Advisor. Gen. Nakasone brings extensive cybersecurity expertise and leadership to the firm. In a recent announcement, Ballistic Ventures, a venture

TLDR: – Naturaz, a Black female-founded startup, raised $1 million in investments during its seed round – The company focuses on formulating and distributing 100% vegan hair care products for curly hair

TLDR: Investors at ISSRDC conference in Boston shared how their investment strategies are adapting to new technologies and shifting market conditions in LEO. Network effects in LEO have driven growth in the

TLDR: Goldman Sachs Asset Management’s alternative investments platform, Goldman Sachs Alternatives, made a $440 million strategic investment in renewable power company BrightNight to support its independent power producer business model. BrightNight, founded

TLDR: – Venture capital deals in East Africa outpaced total corporate finance deals in the first six months of 2024 – VC accounted for 38% of the deals, while mergers and acquisitions

TLDR: The healthcare industry needs more value-add than capital according to Echo Health Ventures CEO Rob Coppedge. The typical 10-year VC fund cycle is not suitable for healthcare innovation. The US healthcare